Frederick O Cope
CIK 1456549 · SVP & CSO · last filed 2018-07-13
Frederick O Cope is a SVP & CSO who has filed 15 SEC Form 4 insider transactions across 1 company since 2012. The most recent filing shows the insider was granted $48.8K of NAVB on Jul 13, 2018. Across all open-market trades the lifetime net is −$24.4K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
15
-$24.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | SVP & CSO | 593,689 | $0.00 | $59 | -$24.4K | 11 | 2018-07-13 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-07-13 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +212,390 | $48.8K | EDGAR |
| 2018-02-22 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +135,694 | $48.8K | EDGAR |
| 2017-02-09 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +88,378 | $46.0K | EDGAR |
| 2016-02-29 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-30 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-03-11 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Sell (S) | −15,000 | -$29.4K | EDGAR |
| 2014-01-31 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-11-08 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Buy (P) | +3,500 | $5.0K | EDGAR |
| 2013-03-15 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Mixed | +82,314 | -$134.9K | EDGAR |
| 2013-02-19 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | — | $0 | EDGAR |